# Compass Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2025

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: DEF 14A
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 08:30 ET
- Period: 2025-06-11
- Accession: 0001171843-25-002573
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184325002573/def14a_042525.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184325002573/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184325002573/def14a_042525.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-002573. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
